Veozah

Product Description

Veozah (fezolinetant) 45mg is an FDA-approved prescription medication specifically indicated for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. VMS involves the sudden feelings of intense heat, sweating, and chills—often referred to as “hot flashes” or “night sweats”—that can significantly disrupt daily life and sleep patterns.

How Veozah Works
Veozah (fezolinetant) 45mg represents a new class of treatment. Before menopause, there is a balance between estrogen and a brain chemical called neurokinin B (NKB) that regulates the body’s temperature control center. As estrogen declines during menopause, this balance is disrupted, leading to hot flashes. Veozah is a neurokinin 3 (NK3) receptor antagonist. It works by blocking NKB binding in the brain’s hypothalamus, effectively restoring balance to the thermoregulatory center and reducing the frequency and severity of hot flashes.

Why Choose Veozah?
The defining feature of Veozah is that it is 100% non-hormonal. For decades, Hormone Replacement Therapy (HRT) was the primary option for treating menopausal symptoms. However, many women cannot take hormones due to medical history (such as a history of breast cancer or blood clots) or simply prefer to avoid them. Veozah offers a highly effective alternative for these patients.

Dosage and Administration
Veozah is available as a 45mg tablet. The recommended dosage is one tablet taken orally once daily, at roughly the same time each day, with or without food.

Important Safety Information
Before starting Veozah, blood work is required to check liver function, as this medication is not recommended for patients with cirrhosis or severe renal impairment. Common side effects may include abdominal pain, diarrhea, insomnia, or back pain. Always consult your pharmacist or healthcare provider to ensure Veozah is right for your specific medical needs.